Reuters logo
BRIEF-Seqirus receives FDA approval of afluria quadrivalent for people 5 years of age and older
September 14, 2017 / 3:51 PM / 2 months ago

BRIEF-Seqirus receives FDA approval of afluria quadrivalent for people 5 years of age and older

Sept 14 (Reuters) - Csl Ltd

* Seqirus receives FDA approval of afluria quadrivalent (influenza vaccine) for people five years of age and older in the U.S.

* Says ‍both afluria quadrivalent (influenza vaccine) and afluria (influenza vaccine), are available in U.S. for 2017-2018 influenza season​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below